Besides, the overexpression of FGF21 delayed the tumor incidence in the diethylnitrosamine-induced liver cancer mice model, but contrarily accelerated the progression of adenoma to HCC, resulting in similar HCC outcomes between overexpression and wild-type groups 98. Here, FGF21 is linked to liver cancer.